Patents by Inventor GIUSEPPE RONZITTI

GIUSEPPE RONZITTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF
    Publication number: 20210040503
    Abstract: The present invention relates to variants of acid-alpha glucosidase and uses thereof.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 11, 2021
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, PASQUALINA COLELLA, FRANCESCO PUZZO
  • TREATMENT OF GLYCOGEN STORAGE DISEASE III
    Publication number: 20200289673
    Abstract: The present invention relates to vectors and compositions for the treatment of glycogen storage disease III.
    Type: Application
    Filed: March 9, 2018
    Publication date: September 17, 2020
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, PATRICE VIDAL
  • ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF
    Publication number: 20190390184
    Abstract: The present invention relates to variants of acid-alpha glucosidase and uses thereof. Said variants are sequence-optimized and/or are linked to a heterogenous signal peptide.
    Type: Application
    Filed: September 12, 2017
    Publication date: December 26, 2019
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, DWIGHT D. KOEBERL, SANG-OH HAN
  • ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF
    Publication number: 20190390224
    Abstract: The present invention relates to variants of acid-alpha glucosidase and uses thereof.
    Type: Application
    Filed: September 12, 2017
    Publication date: December 26, 2019
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, PASQUALINA COLELLA, FRANCESCO PUZZO
  • ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF
    Publication number: 20190390225
    Abstract: The present invention relates to variants of acid-alpha glucosidase and uses thereof.
    Type: Application
    Filed: September 12, 2017
    Publication date: December 26, 2019
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI
  • TREATMENT OF HYPERBILIRUBINEMIA
    Publication number: 20190374619
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 12, 2019
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, FANNY COLLAUD, ANDRÉS MURO, GIULIA BORTOLUSSI
  • Treatment of hyperbilirubinemia
    Patent number: 10471132
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: November 12, 2019
    Assignees: GENETHON, INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
    Inventors: Federico Mingozzi, Giuseppe Ronzitti, Fanny Collaud, Andrés Muro, Giulia Bortolussi
  • TREATMENT OF HYPERBILIRUBINEMIA
    Publication number: 20170028036
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 2, 2017
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, FANNY COLLAUD, ANDRÉS MURO, GIULIA BORTOLUSSI